1. Home
  2. LZB vs PGEN Comparison

LZB vs PGEN Comparison

Compare LZB & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$35.79

Market Cap

1.4B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.24

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZB
PGEN
Founded
1927
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
LZB
PGEN
Price
$35.79
$4.24
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$39.00
$8.33
AVG Volume (30 Days)
322.5K
2.7M
Earning Date
06-16-2026
05-13-2026
Dividend Yield
2.75%
N/A
EPS Growth
N/A
N/A
EPS
1.65
N/A
Revenue
$2,349,433,000.00
$230,981,000.00
Revenue This Year
$1.89
$1,115.92
Revenue Next Year
$2.09
$81.04
P/E Ratio
$21.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.03
$1.26
52 Week High
$44.49
$5.47

Technical Indicators

Market Signals
Indicator
LZB
PGEN
Relative Strength Index (RSI) 56.82 54.42
Support Level $35.32 $4.12
Resistance Level $39.79 $4.40
Average True Range (ATR) 0.90 0.20
MACD -0.02 0.01
Stochastic Oscillator 66.62 61.06

Price Performance

Historical Comparison
LZB
PGEN

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: